Home Cart Sign in  
Chemical Structure| 144542-43-8 Chemical Structure| 144542-43-8
Chemical Structure| 144542-43-8

(R)-Methyl 2-oxooxazolidine-4-carboxylate

CAS No.: 144542-43-8

4.5 *For Research Use Only !

Cat. No.: A291143 Purity: 97%

Change View

Size Price

US Stock

Global Stock

In Stock
250mg łÇî¶ÊÊ Inquiry Inquiry
1g łËò¶ÊÊ Inquiry Inquiry
5g łÇÇͶÊÊ Inquiry Inquiry
25g ł§îî¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 250mg

    łÇî¶ÊÊ

  • 1g

    łËò¶ÊÊ

  • 5g

    łÇÇͶÊÊ

  • 25g

    ł§îî¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ 144542-43-8 ]

CAS No. :144542-43-8
Formula : C5H7NO4
M.W : 145.11
SMILES Code : O=C([C@@H]1NC(OC1)=O)OC
MDL No. :MFCD11505659
InChI Key :PZIWTVKXOORXAZ-GSVOUGTGSA-N
Pubchem ID :385465

Safety of [ 144542-43-8 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Calculated chemistry of [ 144542-43-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 0
Fraction Csp3 0.6
Num. rotatable bonds 2
Num. H-bond acceptors 4.0
Num. H-bond donors 1.0
Molar Refractivity 33.71
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

64.63 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.08
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.33
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-1.11
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.95
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.15
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-0.29

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.4
Solubility 57.8 mg/ml ; 0.398 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.57
Solubility 39.4 mg/ml ; 0.272 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.21
Solubility 88.7 mg/ml ; 0.611 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.42 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.47
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 144542-43-8 ]

Amides

Chemical Structure| 98541-64-1

A358497 [98541-64-1]

tert-Butyl (S)-(2-oxooxetan-3-yl)carbamate

Similarity: 0.86

Chemical Structure| 126330-77-6

A549770 [126330-77-6]

(R)-tert-Butyl (2-oxooxetan-3-yl)carbamate

Similarity: 0.86

Chemical Structure| 885321-46-0

A303310 [885321-46-0]

(R)-4-tert-Butyl 3-methyl morpholine-3,4-dicarboxylate

Similarity: 0.81

Chemical Structure| 212650-43-6

A479662 [212650-43-6]

4-Boc-3-Morpholinecarboxylic acid

Similarity: 0.79

Chemical Structure| 783350-37-8

A887793 [783350-37-8]

(S)-4-(tert-Butoxycarbonyl)morpholine-3-carboxylic acid

Similarity: 0.79

Esters

Chemical Structure| 98541-64-1

A358497 [98541-64-1]

tert-Butyl (S)-(2-oxooxetan-3-yl)carbamate

Similarity: 0.86

Chemical Structure| 126330-77-6

A549770 [126330-77-6]

(R)-tert-Butyl (2-oxooxetan-3-yl)carbamate

Similarity: 0.86

Chemical Structure| 885321-46-0

A303310 [885321-46-0]

(R)-4-tert-Butyl 3-methyl morpholine-3,4-dicarboxylate

Similarity: 0.81

Chemical Structure| 3190-70-3

A124132 [3190-70-3]

(S)-4-Isobutyloxazolidine-2,5-dione

Similarity: 0.76

Chemical Structure| 51248-35-2

A124913 [51248-35-2]

Isobutyloxazolidine-2,5-dione

Similarity: 0.76

Related Parent Nucleus of
[ 144542-43-8 ]

Oxazolidines

Chemical Structure| 1219384-60-7

A136166 [1219384-60-7]

Oxazolidine-4-carboxylic acid hydrochloride

Similarity: 0.83

Chemical Structure| 4042-43-7

A125191 [4042-43-7]

(R)-4-Methyloxazolidin-2-one

Similarity: 0.76

Chemical Structure| 4042-35-7

A791172 [4042-35-7]

(S)-4-Methyloxazolidin-2-one

Similarity: 0.76

Chemical Structure| 3190-70-3

A124132 [3190-70-3]

(S)-4-Isobutyloxazolidine-2,5-dione

Similarity: 0.76

Chemical Structure| 51248-35-2

A124913 [51248-35-2]

Isobutyloxazolidine-2,5-dione

Similarity: 0.76